Delivery Order SPE2DB20D2104-SPE2DB23FR69A
Award Date 1/5/23
Potential Completion Date 1/6/23
Potential Value $2.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,149.03 for the supply of RESTASIS 0.05% eye emulsion. The contract was awarded on February 28, 2022, by the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,152.41 for the supply of RESTASIS 0.05% eye emulsion. The contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of September 9, 2021. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,114.52 for the supply of RESTASIS 0.05% eye emulsion. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 10, 2021. The contract is a firm-fixed-price delivery order, and there is no set-aside designation. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,171.46, is for the delivery of RESTASIS 0.05% eye emulsion, a specialty pharmaceutical product, with a completion date of December 15, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,178.12 for the supply of RESTASIS 0.05% eye emulsion. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 23, 2023. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,239.80 for the supply of Restasis 0.05% eye emulsion. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has an ultimate completion date of June 6, 2023. The contract is a firm fixed-price type, and there is no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of RESTASIS 0.05% eye emulsion to the Defense Logistics Agency (DLA). The award, valued at $1,721.00, is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which has a total potential value of $999,999,999.00 and runs through November 2026. The contract is for the provision of a wide range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $6,944.92 for the supply of Restasis 0.05% eye emulsion. The award was made by the Defense Logistics Agency (DLA) on December 27, 2021, with a completion date of December 28, 2021. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order for the medical product "RESTASIS 0.05% EYE EMULSION 30S". The $6,098.12 firm fixed-price award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 28, 2023. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA, valued at up to $999,999,999 and running...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of RESTASIS 0.05% eye emulsion 30s, a prescription eye medication. The contract, valued at $10,228.81, was awarded by the Defense Logistics Agency (DLA) and has a completion date of July 12, 2023. This delivery order contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...